- Sareum to Present at BioTrinity 2022 Conference
- Sareum notes acquisition of Sierra Oncology by GSK
- Second Price Monitoring Extn
- Price Monitoring Extension
- European Patent Granted for Sareumâ€™s SDC-1802
- SDC-1801: Preclinical Toxicology Report Received
- Results of EGM
- Half-year Report
- Publication of Circular; Notice of General Meeting
- Correction - Issue of Warrants
Sareum Holdings PLC (RYH0:STU) closed at 2.18, 70.85% above the 52 week low of 1.28 set on Mar 11, 2022.
1.28Mar 11 20226.10Jul 30 2021
Markit short selling activity
|Market cap||131.03m GBP|
|EPS (TTM)||-0.0273 |
Data delayed at least 15 minutes, as of Jun 27 2022.